NGGT Inc. is a pioneering gene therapy company leading the charge in developing innovative treatments for genetic disorders. With our groundbreaking projects, NGGT001 for Biett’s Crystaline Dystrophy (BCD) and NGGT002 for Phenylketonuria (PKU) , both granted Orphan Drug Designation (ODD) by the FDA and cleared for Phase I/II clinical trials, we are at the forefront of medical innovation. What sets us apart is our state-of-the-art cGMP facilities, equipped with cutting-edge technology, allowing us to produce all our products for clinical trials in-house. This vertical integration ensures rigorous quality control and accelerates the development timeline, bringing us closer to providing life-changing therapies to patients worldwide. At NGGT Inc., we are driven by our commitment to revolutionize healthcare through the power of gene therapy.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Walnut Creek, Ca 94597, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Walnut Creek, CA
Nggt Inc. Questions
Nggt Inc.'s LinkedIn profile is https://www.linkedin.com/company/nogginc
Nggt Inc. has
2 employees.
View email and phone details for 2
employees at Nggt Inc..
Nggt Inc.'s industry is
Biotechnology Research
Nggt Inc.'s top competitors are
Florica Therapeutics,
Golden West Biologicals, Inc.,
Celltheon Corporation,
Halo Labs,
Halo Biosciences,
Komo Biosciences,
Manzanita Pharmaceuticals Inc,
Luca Healthcare,
Neucyte,
Dark Horse Consulting Group Inc..
Nggt Inc.'s categories are Biotechnology Research
Nggt Inc.'s founding year is 2020
